![]() Trefoil Therapeutics Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases. | ![]() Vedanta Biosciences Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. | ![]() Alzheon Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. | |||
Founding Date | Founding Date 2014 | Founding Date 2014 | Founding Date 2010 | Founding Date 2013 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Branford, US HQ | Locations Cambridge, US HQ | Locations Framingham, US HQ | Locations Cambridge, US HQ Boston, US |
Employees | Employees 138% increase | Employees 10 | Employees 1381% increase | Employees 3310% increase | Employees 67 |
Financial | |||||
Net income | Net income N/A | Net income ($11m) (FY, 2025) | Net income N/A | Net income ($5.5m) (FY, 2017) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 28m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 68m (almost 5 years ago) | Latest funding round $ 15.8m (almost 9 years ago) | Latest funding round $ 150m (about 4 years ago) |
Total funding raised | Total funding raised $ 33.2m | Total funding raised $ 20.8m | Total funding raised $ 185.5m | Total funding raised $ 37.1m | Total funding raised $ 236m |

Azitra is a biotech comapny developing microbiome-based therapeutics to treat skin diseases.
View company
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
View company
Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
View company
MOMA Therapeutics is a biotechnology company.
View company